BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10714040)

  • 1. Are stimulants overprescribed?
    Diller LH
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269; author reply 270-1. PubMed ID: 10714040
    [No Abstract]   [Full Text] [Related]  

  • 2. Are stimulants overprescribed?
    Perry R; Gilbert EM; Angkustsiri K
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269-70; author reply 270-1. PubMed ID: 10714041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is Ritalin prescribed insufficiently to hyperactive children in Nordland?].
    Neraal T
    Tidsskr Nor Laegeforen; 2001 May; 121(14):1735-6. PubMed ID: 11446022
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 5. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
    Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authentic faux diamonds and attention deficit disorder.
    Anijar K; Gabbard D
    Am J Bioeth; 2005; 5(3):67-70. PubMed ID: 16006371
    [No Abstract]   [Full Text] [Related]  

  • 7. Attention-deficit-hyperactivity disorder.
    Diller LH
    N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
    [No Abstract]   [Full Text] [Related]  

  • 8. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 9. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescribing of stimulants for ADHD in Nordland County].
    Asheim H; Nilsen KB; Johansen K; Furu K
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2360-2. PubMed ID: 17895938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in medication treatment for ADHD.
    Castle L; Aubert RE; Verbrugge RR; Khalid M; Epstein RS
    J Atten Disord; 2007 May; 10(4):335-42. PubMed ID: 17449832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL; Jhung MA; Budnitz DS
    N Engl J Med; 2006 May; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract]   [Full Text] [Related]  

  • 14. Ritalin use in BC.
    Rees A
    CMAJ; 2000 Mar; 162(6):753-4. PubMed ID: 10750449
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity really IS common...and a new warning about treatment.
    Child Health Alert; 2005 Nov; 23():3. PubMed ID: 16416539
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of attention-deficit/hyperactivity disorder.
    Pierce K
    Pediatr Ann; 2011 Nov; 40(11):556-62. PubMed ID: 22066507
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A; Nanan R
    Pediatrics; 2008 Jul; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract]   [Full Text] [Related]  

  • 19. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM; Friedman RA; Knilans TK; ;
    Pediatrics; 2008 Aug; 122(2):451-3. PubMed ID: 18676566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.